Anthropic acquires Mithril Medicine, one-person biotech using Claude for drug development

According to R&D World and Anthropic announcements, Anthropic acquired Mithril Medicine in July 2026, a Cambridge-based biotech company with one full-time employee (founder Cody Tranbarger) directing part-time consultants and 11 external laboratories using Claude to manage experiments and logistics. Mithril's programs targeting two rare muscular dystrophies became Anthropic's first internal drug-development programs, with Tranbarger joining Anthropic to lead broader internal drug development efforts.